Douglas Keller

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 2

Top Topics

Circulating Tumor Cells

Risk Assessment

Molecular Docking

Top Venues

Sanofi

Duke University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sanofi

United States

Senior Director :: Preclinical Safety

DuPont Haskell Laboratory Sep 27 1988 - May 25 1998

United States

Staff Scientist :: Toxicology

Education History

Duke University

United States

PHD :: Pharmacology

Publications

Jonathan A Phillips, Taraka Sai Pavan Grandhi, Myrtle Davis, Jean-Charles Gautier, Niresh Hariparsad, Douglas Keller, Radhakrishna Sura, Terry R Van Vleet
A pharmaceutical industry perspective on microphysiological kidney systems for evaluation of safety for new therapies. Lab on a chip 20 (3) (2020)
Andreas R Baudy, Monicah A Otieno, Philip Hewitt, Jinping Gan, Adrian Roth, Douglas Keller, Radhakrishna Sura, Terry R Van Vleet, William R Proctor
Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry. Lab on a chip 20 (2) (2019)